<code id='F509D36C48'></code><style id='F509D36C48'></style>
    • <acronym id='F509D36C48'></acronym>
      <center id='F509D36C48'><center id='F509D36C48'><tfoot id='F509D36C48'></tfoot></center><abbr id='F509D36C48'><dir id='F509D36C48'><tfoot id='F509D36C48'></tfoot><noframes id='F509D36C48'>

    • <optgroup id='F509D36C48'><strike id='F509D36C48'><sup id='F509D36C48'></sup></strike><code id='F509D36C48'></code></optgroup>
        1. <b id='F509D36C48'><label id='F509D36C48'><select id='F509D36C48'><dt id='F509D36C48'><span id='F509D36C48'></span></dt></select></label></b><u id='F509D36C48'></u>
          <i id='F509D36C48'><strike id='F509D36C48'><tt id='F509D36C48'><pre id='F509D36C48'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:63
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead
          Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

          HasPhRMAlostitsfangs?Are11th-hourchangesominousforclinicaltrials?Andwhat’snextinpainmedicine?Wecover

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          WATCH: Why do our ears pop?

          Whatcausesourearstopopandwhataretheydoing,exactly?AlexHogan,MatthewOrr/STATTakingoffinanairplanealwa